n-methylscopolamine has been researched along with Alzheimer Disease in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (55.56) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Birdsall, NJ; Caulfield, MP; Cross, AJ; Crow, T; Straughan, DW | 1 |
| Henke, H; Lang, W | 1 |
| Adem, A; Cowburn, RF; Lannfelt, L; Venizelos, N; Vestling, M; Winblad, B | 1 |
| Jung, MH; Kong, JY; Lee, MJ; Park, JG | 1 |
| Amenta, F; Amici, S; El-Assouad, D; Gallai, V; Parnetti, L; Ricci, A; Tayebati, SK | 1 |
| Benna, P; Bergamasco, B; Eva, C; Ferrero, P; Genazzani, E; Ravizza, L; Rebaudengo, N; Rocca, P | 1 |
| Cortés, R; Palacios, JM; Probst, A; Ulrich, J | 1 |
| Huey, LY; Janowsky, DS; Kennedy, B; Risch, SC; Ziegler, M | 1 |
| Davous, P; Lamour, Y | 1 |
9 other study(ies) available for n-methylscopolamine and Alzheimer Disease
| Article | Year |
|---|---|
Cortical muscarinic receptor subtypes and Alzheimer's disease.
Topics: Alzheimer Disease; Benzodiazepinones; Binding, Competitive; Cerebral Cortex; Dementia; Humans; N-Methylscopolamine; Parasympatholytics; Pirenzepine; Receptors, Cholinergic; Receptors, Muscarinic; Scopolamine Derivatives | 1982 |
Cholinergic receptor binding and autoradiography in brains of non-neurological and senile dementia of Alzheimer-type patients.
Topics: Aged; Alzheimer Disease; Autoradiography; Brain; Bungarotoxins; Dementia; Frontal Lobe; Gyrus Cinguli; Hippocampus; Humans; N-Methylscopolamine; Receptors, Cholinergic; Receptors, Muscarinic; Receptors, Nicotinic; Scopolamine Derivatives; Temporal Lobe | 1983 |
Characterization of muscarinic acetylcholine receptors in cultured adult skin fibroblasts: effects of the Swedish Alzheimer's disease APP 670/671 mutation on binding levels.
Topics: Aged; Alzheimer Disease; Amyloid beta-Protein Precursor; Cells, Cultured; Fibroblasts; Humans; Mutation; N-Methylscopolamine; Parasympatholytics; Pirenzepine; Quinuclidinyl Benzilate; Receptors, Muscarinic; Reference Values; Scopolamine Derivatives; Skin; Sweden | 1995 |
Synthesis of 5-(4-alkoxy-[1,2,5]thiadiazol-3-yl)-3-methyl-1,2,3,4-tetrahydropyrimidi ne oxalate salts and their evaluation as muscarinic receptor agonists.
Topics: Alzheimer Disease; Binding, Competitive; Humans; Magnetic Resonance Spectroscopy; Molecular Structure; Muscarinic Agonists; N-Methylscopolamine; Protein Binding; Pyrimidines; Receptor, Muscarinic M1; Receptors, Muscarinic; Recombinant Proteins; Thiadiazoles | 2000 |
Peripheral blood lymphocytes muscarinic cholinergic receptor subtypes in Alzheimer's disease: a marker of cholinergic dysfunction?
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Dementia, Vascular; Female; Humans; In Vitro Techniques; Lymphocytes; Male; Middle Aged; N-Methylscopolamine; Parasympatholytics; Radioligand Assay; Receptor, Muscarinic M2; Receptor, Muscarinic M3; Receptor, Muscarinic M4; Receptor, Muscarinic M5; Receptors, Muscarinic; Tritium | 2001 |
An analysis of lymphocyte 3H-N-methyl-scopolamine binding in neurological patients. Evidence of altered binding in Alzheimer's disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Child; Child, Preschool; Humans; Lymphocytes; Middle Aged; N-Methylscopolamine; Nervous System Diseases; Parasympathomimetics; Scopolamine Derivatives; Sex Characteristics; T-Lymphocytes; Tritium | 1991 |
Differential modification of muscarinic cholinergic receptors in the hippocampus of patients with Alzheimer's disease: an autoradiographic study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Autoradiography; Brain; Cell Count; Cholinergic Fibers; Female; Hippocampus; Humans; Male; Middle Aged; N-Methylscopolamine; Receptors, Muscarinic; Scopolamine Derivatives | 1988 |
Effects of physostigmine on pulse, blood pressure, and serum epinephrine levels.
Topics: Adult; Alzheimer Disease; Arrhythmias, Cardiac; Blood Pressure; Depressive Disorder; Epinephrine; Humans; Hypertension; Middle Aged; N-Methylscopolamine; Parasympatholytics; Physostigmine; Pulse; Scopolamine Derivatives | 1985 |
Bethanechol decreases reaction time in senile dementia of the Alzheimer type.
Topics: Adult; Aged; Alzheimer Disease; Bethanechol Compounds; Drug Therapy, Combination; Humans; Middle Aged; N-Methylscopolamine; Parasympatholytics; Psychomotor Performance; Reaction Time; Scopolamine Derivatives | 1985 |